| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/SMIM.1995.0029 |
| P698 | PubMed publication ID | 8520029 |
| P2093 | author name string | J N Ihle | |
| P433 | issue | 4 | |
| P304 | page(s) | 247-254 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Seminars in Immunology | Q15762658 |
| P1476 | title | The Janus protein tyrosine kinases in hematopoietic cytokine signaling | |
| P478 | volume | 7 |
| Q28139288 | Early signaling pathways activated by c-Kit in hematopoietic cells |
| Q79405603 | Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway |
| Q35548966 | Erythropoietin in stroke therapy: friend or foe |
| Q40235023 | Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells |
| Q28266613 | Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome |
| Q36591400 | Identification of somatic JAK1 mutations in patients with acute myeloid leukemia |
| Q89682918 | Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells |
| Q48109284 | JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders. |
| Q40559879 | Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase |
| Q37815509 | Janus kinase 2 inhibitors in myeloproliferative disorders |
| Q24322021 | Janus kinases in immune cell signaling |
| Q40035458 | Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways |
| Q24305025 | Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors |
| Q30997978 | Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm |
| Q46553272 | Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver |
| Q92834637 | Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia |
| Q54581202 | Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. |
| Q40622102 | Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid. |
| Q24554307 | Regulatory and signaling properties of the Vav family |
| Q36836799 | TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia |
| Q92128519 | Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How? |
| Q36312070 | The Drosophila cyst stem cell lineage: Partners behind the scenes? |
| Q27931859 | The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity |
| Q35198415 | The ins and outs of STAT1 nuclear transport |
| Q34234067 | The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice |
| Q35156746 | Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia |
Search more.